Skip to main content
. 2019 Jan 29;10(9):942–952. doi: 10.18632/oncotarget.26604

Figure 1. Molecular profile assessed by immunohistochemistry and next generation sequencing.

Figure 1

All immunoreactivity positive cases (black bars) and patients with genetic mutations (grey bars) are represented as percentage of enrolled subjects.